Skip to main content
NCBI home page
Journal of Ophthalmology logoLink to Journal of Ophthalmology
. 2022 May 5;2022:6780901. doi: 10.1155/2022/6780901

Association between Cataract Surgery and Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Lihong Yang 1, Hongxun Li 1,✉, Xinheng Zhao 1,2, Ye Pan 1
PMCID: PMC9098349  PMID: 35573811

Abstract

Purpose

We performed a systematic review and meta-analysis to evaluate the association between cataract surgery and the development and progression of AMD.

Methods

This meta-analysis was registered at PROSPERO (CRD42017077962). We conducted a systematic literature search in August 2020 in Embase and PubMed and included cohort studies, case-control studies, or randomized controlled trials (RCTs) if they examined the association between cataract surgery and AMD. Odds ratio (OR) was used as a measure of the association with a random effect model. The analysis was further stratified by factors that could affect the outcomes.

Results

15 studies were included in this study. In the overall analysis, cataract surgery was significantly associated with the incidence of late AMD (OR, 1.80; 95% CI, 1.26–2.56; P = 0.001), particularly geographic atrophy (OR, 3.20; 95% CI, 1.90–5.39; P ≤ 0.001). No significant associations were observed between cataract surgery and the incidence of early AMD. Subgroup analysis showed that the OR for incidence of early and late AMD was significantly higher for cataract surgery performed more than 5 years compared with less than 5 years. We also found an increased risk of progression of AMD after cataract surgery performed more than 5 years (OR, 1.97; 95% CI, 1.29–3.01; P = 0.002).

Conclusions

Our results suggest that cataract surgery may be associated with an increased risk of late AMD development and AMD progression. In addition, increasing the follow-up time since cataract surgery may further increase the risk for the development and progression of AMD. In the future, prospective multicenter studies with well-designed RCTs are required to confirm our findings.

1. Introduction

Cataract and age-related macular degeneration (AMD) are the two important causes of visual impairment and blindness in elderly people [1]. Both conditions are strongly age related, and each has a number of identified risk factors [2]. With rapidly aging populations and longer life expectancy, the WHO has estimated that the number of people with cataract blindness will increase to 40 million in 2025 [3]. Cataract surgery is the most frequent operation in ophthalmology and results in improved visual function [4]. Neovascular AMD is characterized by subretinal choroidal neovascularization and can be treated by intravitreal injection of anti-VEGFs [5]. Notably, AMD is also a common retinal comorbidity in patients undergoing cataract surgery, and surgeons should have additional concerns when patients are also known to have AMD [6].

Clarifying whether there are different risks between types of AMD after cataract surgery is very important from an informed consent perspective. However, the potential for cataract surgery to increase the risk of developing AMD is a long-standing clinical question, [7, 8] and the findings from epidemiological studies regarding these associations have been inconsistent [8–19]. Since then, several other studies investigating cataract surgery for AMD have been published [17, 20, 21]. Ho et al. [17] and Daien et al. [20] reported an increased risk of developing AMD following cataract surgery, whereas Park et al. suggested that the association between cataract surgery and AMD is uncertain in the current era of phacoemulsification [21]. There are several possible reasons for the inconsistent findings among studies. Differences in the duration of follow-up, response rates, sample source, study design, and strategies for adjusting for confounders could affect the results and might explain the inconsistent findings [7]. A previous meta-analysis of the association between cataract surgery and the risk of AMD was performed, but the possible influencing factors were not specifically evaluated [22, 23].

To address these issues, we conducted a meta-analysis to examine the association between cataract surgery and the development and progression of AMD, allowing for differences in the sample source, AMD type, and duration of follow-up.

2. Materials and Methods

2.1. Search Strategy

We attempted to conform to the Meta-analysis of Observational Studies (MOOSE) guidelines in the report of this meta-analysis [24]. This meta-analysis was registered at PROSPERO (CRD42017077962). Randomized controlled trials (RCTs) were included in this study in order to provide robust evidence with high-quality existing literature [25, 26]. Cohort studies and case-control studies were also included, which could address the temporal relationship between cataract surgery and AMD. We conducted a systematic literature search in August 2020, using Embase and PubMed, with the following search terms: cataract extraction (cataract extr∗, phaco∗), macular degeneration, choroidal neovascularization, and geographic atrophy. The detailed search strategy for the Embase and PubMed databases is described in the protocol presented in Additional file 1. Manual searches of all relevant trials and review articles were also performed. There were no language restrictions in the search for trials. We also reviewed all relevant trials included in previous systematic reviews and meta-analyses [22, 27].

2.2. Eligibility Criteria

The inclusion criteria were as follows: (1) studies evaluating the effect of cataract surgery on the development or progression of AMD; (2) cohort studies, case-control studies, or RCTs; and (3) studies with summary estimates, such as odds ratios (ORs) or hazards ratios (HRs) with 95% confidence intervals (CIs), reported or calculated in the article. We excluded studies if they were cross-sectional studies because they could not establish a causal association between cataract surgery and AMD.

2.3. Data Extraction and Quality Assessment

All data from eligible studies were independently extracted by two independent investigators (Hongxun Li and Xinheng Zhao). The results were compared, and disagreements were resolved by consensus. We extracted the following information: first author, publication year, study design, sample source, sample size, age range of the study participants, follow-up time, AMD diagnosis and grading criteria, summary estimates and the corresponding 95% CIs, and confounding factors adjusted for. We assessed the methodological quality of observational studies according to the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool [28]. The Cochrane Collaboration's tool for assessing the risk of bias was used for randomized trials [29].

2.4. Outcome Measures

The primary outcomes were as follows: the incidence of early AMD, defined by the presence of soft indistinct drusen or drusen associated with retinal pigment epithelial (RPE) depigmentation or increased retinal pigment at follow-up when none of these lesions was present at baseline and the incidence of late AMD, defined as the appearance of neovascular AMD or geographic atrophy at follow-up in eyes without either lesion at baseline. An eye was excluded from the incidence calculations for early or late AMD if either was already present at baseline. The secondary outcome was the progression of AMD, defined as an increase in maculopathy severity from baseline to the follow-up examination [30].

2.5. Statistical Analyses

Most studies used logistic regression models to adjust for confounders; therefore, we chose adjusted ORs as the measure of association between cataract surgery and AMD. For studies [17, 31] reporting only RRs or HRs, the ORs were used as estimates of the RRs or HRs because the incidence of AMD is extremely low in the general population. When studies with the same population or subpopulation were available, we considered the estimates from the most recent or most informative report. For studies [11, 15] t that reported only stratified results (e.g., by AMD subtype), we adopted the strategy recommended by Hamling et al. to calculate a combined OR [32]. We performed stratified analyses by the duration of follow-up, adjustment for early-stage AMD lesions, sample source, AMD type, and AMD subtype to provide robust evidence and investigate potential sources of between-study heterogeneity. We also performed a sensitivity analysis by both fixed-effects and random-effects models. Although both models obtained similar findings, the results from the random-effects models are presented here because of the different study designs, durations of follow-up, and strategies for adjusting for confounders that were involved in the original trials. Under these circumstances, the random-effects model approach was more conservative in medical decision-making contexts [33]. Statistical heterogeneity among studies was assessed with I2 and chi-squared tests. Heterogeneity was considered significant if P < 0.1 and considered high if the I2 value was above 75% [34, 35]. Publication bias was assessed by Egger's test [36]. Data were analyzed using the use of STATA version 12.0 (StataCorp LP, College Station, TX).

3. Results

3.1. Included Studies and Study Characteristics

We identified 863 studies from the initial literature search (Figure 1). After checking for duplicates and eliminating references that were deemed “not relevant” by titles and abstracts, we retrieved 29 full-text articles for detailed assessment. Our final analysis included 12 population-based cohort studies [9–12, 15–19, 30, 31, 37], 2 randomized controlled trials [25, 26], and 1 case-control study [8]. The baseline characteristics of the study participants are shown in Table 1. The studies were published between 1998 and 2017. The follow-up length of the cohort studies ranged from 1.5 to 20 years. Five studies [9, 10, 12, 30, 37] were from two cohort studies (the Beaver Dam Eye Study and the Blue Mountains Eye Study) with different follow-up times. Table S1 shows the adjusted study-specific OR estimates (95% CIs) obtained from each study and the covariates that were adjusted for in the multivariate analyses (see Additional file 2). Seven studies (7 of 15) had a high risk of bias in at least one domain. The overall risk of bias of the included studies is shown in Additional file 3 (Figure S1. Quality of the included trials).

Figure 1.

Figure 1

Open in a new tab

Study selection process. AMD = age-related macular degeneration.

Table 1.

Characteristics of the included studies.

Authors (yr) Region Sample source Sample size Age (yrs) Length of follow-up AMD assessment Overall risk of bias
Cohort studies
Klein et al. (1998) [30] US Population-based 3684 43–86 5 yr follow-up W Moderate
Klein et al. (2002) [9] US Population-based 2764 43–86 10 yr follow-up W Moderate
Wang et al. (2003) [37] Australia/USA Population-based 6019 ≥43 5 yr follow-up W Moderate
Buch et al. (2008) [19] Denmark Population-based 369 60–80 14 yr follow-up W Serious
Cugati et al. (2006) [10] Australia Population-based 3654 ≥49 10 yr follow-up W, I Moderate
Kaiserman et al. (2007) [31] Israel Population-based 5913 ＞50 1.5 yr follow-up FP, FA Serious
Ho et al. (2008) [11] Netherlands Population-based 6032 ≥55 5.7 yr follow-up I Serious
Baatz et al. (2018) [20] Germany Clinic-based 1152 55–95 1 yr follow-up FP, FA Serious
Chew et al. (2009) [15] USA Clinic-based 4577 55–80 5 yr follow-up A Moderate
Klein et al. (2012) [12] USA Population-based 1913 43–86 20 yr follow-up W Moderate
Wang et al. (2012) [16] Australia Clinic-based 2029 ≥65 3 yr follow-up W Moderate
Buch et al. (2009) [18] Taiwan Population-based 3465 50–74 5 yr follow-up FP, FA Serious
Randomized controlled trials
Hooper et al. (2009) [25] Australia Clinic-based 56 71–92 6 mo follow-up FA Moderate
Brunner et al. (2013) [26] Austria Clinic-based 54 80 6 mo follow-up FP Serious
Case-control studies
Sutter et al. (2007) [8] Switzerland Clinic-based 49 ＞55 — FP, FA Serious
Open in a new tab

AMD = age-related macular degeneration; I = International AMD classification; W = Wisconsin AMD grading system; FP = fundus photography; FA = fluorescein angiography; A = Age-Related Eye Disease Study system classification.

3.2. Quantitative Data Synthesis

In the overall analysis, cataract surgery was significantly associated with a higher incidence of late AMD [10–12, 16, 18] (OR, 1.80; 95% CI, 1.26–2.56; P = 0.001, I2 = 27.9%), and a lower incidence of early AMD [10–12, 16, 18], but no statistically significant association was observed (OR, 1.15; 95% CI, 0.96–1.37; P = 0.139, I2 = 0%). We did find significant associations of cataract surgery with the progression of AMD (OR, 1.40; 95% CI, 1.10–1.80; P = 0.014, I2 = 2.2%) (Figure 2). Table 2 shows the subgroup analyses based on the following stratified factors.

Figure 2.

Figure 2

Open in a new tab

Risk estimates of the association between cataract surgery and the development and progression of age-related macular degeneration (AMD) in the overall analysis.

Table 2.

Subgroup analyses of cataract surgery and the incidence of age-related macular degeneration.

  Subgroups No. of studies Pooled OR Significance Heterogeneity
95% CI P value I 2, (%) P value
Study design Cohort studies            
 Early AMD 5 1.15 0.96－1.37 0.139 0 0.895
 Late AMD 5 1.80 1.26－2.56 0.001 27.9 0.236
Case-control studies            
 Late AMD 1 1.55 1.24－1.94 ≤0.001 NA NA
Follow-up length
 For early AMD ≤5 yrs 2 0.95 0.72－1.25 0.700 0 0.503
＞5 yrs 4 1.32 1.05－1.67 0.018 0 0.993
 For late AMD ≤5 yrs 3 1.97 0.73－5.31 0.181 80.6 0.006
＞5 yrs 4 2.15 1.54－2.98 ≤0.001 0 0.719
AMD type
 Sample source Early sample source            
 Population-based 4 1.16 0.95－1.41 0.137 0 0.803
 Clinic-based 1 1.07 0.68－1.68 0.769 NA NA
Late            
 Population-based 4 2.02 1.50－2.72 ≤0.001 0 0.728
 Clinic-based 1 0.73 0.29－1.83 0.503 NA NA
Adjusted for early Yes 2 2.39 1.43－3.99 0.001 0 0.626
AMD lesions No 2 1.85 1.29－2.67 0.001 0 0.508
Open in a new tab

AMD = age-related macular degeneration; CI = confidence interval; OR = odds ratio.

3.2.1. AMD Subtype

When we stratified the studies by AMD subtype, the pooled OR for neovascular AMD was 2.08 (95% CI, 1.21–3.58; P = 0.008, I2 = 79.8%), and the heterogeneity was decreased substantially by removing clinic-based studies (OR, 2.57; 95% CI, 1.76–3.76; P ≤ 0.001, I2 = 28.8%) (Figure S2, see Additional file 4). The pooled OR for the geographic atrophy subtype of AMD was 3.20 (95% CI, 1.90–5.39; P ≤ 0.001, I2 = 0%) (Figure 3).

Figure 3.

Figure 3

Open in a new tab

Forest plot evaluating the association between cataract surgery and the development of late age-related macular degeneration (AMD) based on AMD subtype.

3.2.2. Sample Source

In the analyses stratified by sample source, the pooled estimates for early AMD were systematically higher in population-based studies than in clinic-based studies, but the association was not statistically significant for either group (FigureS3, see Additional file 5); in contrast, the pooled estimates for late AMD were statistically significant for population-based studies (OR, 2.02; 95% CI, 1.50–2.72; P ≤ 0.001, I2 = 0%) (Figure S4, see Additional file 5).

3.2.3. Adjusted Variables

Studies adjusted for early AMD lesions were considered. We found higher risk estimates for late AMD in the early AMD lesion-adjusted group than in the group that did not have early AMD lesions, but the difference was not statistically significant (Figure S5, see Additional file 7).

3.2.4. Follow-Up Length

When we stratified the studies by follow-up duration, no statistically significant associations were observed between cataract surgery and the incidence of early AMD and late AMD in patients with a follow-up duration ≤5 years (Figure 4). In contrast, both ORs for longer follow-up durations (>5 years) showed significant associations. We also found significant associations of cataract surgery with the progression of AMD for a longer follow-up duration (OR, 1.97; 95% CI, 1.29–3.01; P = 0.002), but the pooled OR was not statistically significant for a shorter follow-up duration (Figure 4).

Figure 4.

Figure 4

Open in a new tab

Forest plot evaluating the association between cataract surgery and the development and progression of age-related macular degeneration (AMD) based on follow-up duration. ∗The result from Blue Mountains Eye Study was included in this subgroup meta-analysis.

3.3. Sensitivity Analysis and Publication Bias

There was no evidence of publication bias for the incidence of AMD among studies by Egger's test (early AMD, P = 0.22; late AMD, P = 0.64). The sensitivity analyses showed that the OR and 95% CI were not altered substantially with either the fixed-effects model or the random-effects model (data not shown).

4. Discussion

Age-related eye diseases are expected to increase with an aging population. Cataract surgery is regarded as routine surgery and an effective treatment for cataract-induced vision loss. It remains a matter of debate whether cataract surgery itself increases the risk of AMD progression or AMD development [38]. Therefore, clarifying the importance of considering these risks will help both patients and physicians make more informed decisions.

In our meta-analysis, we found that cataract surgery was associated with an increased risk of late AMD development and AMD progression in the overall analyses. However, an association was not detected between cataract surgery and the incidence of early AMD in the overall analyses. A previous meta-analysis reported that the association between the progression of AMD and cataract surgery was not significant at the 6–12 month follow-up, and further research with a longer follow-up is encouraged [22]. Thus, when we compared the longer follow-up duration (>5 years) with the shorter follow-up duration (≤5 years), the odds were significantly different from each other. Our findings suggest that the greater the length of time since cataract surgery, the greater the odds were for the incidence of AMD and AMD progression.

To test the robustness of our results, we conducted subgroup analyses that permitted us to better understand the association in different subgroups. When we stratified the studies by AMD subtype, we found a stronger relationship with geographic atrophy than with neovascular AMD. The different pathophysiological characteristics in the natural history for both conditions differed by the same risk factor [39]. Our findings suggest that studies with primarily clinic-based patient samples have not found an association between cataract surgery and the incidence of late AMD. The possible reasons for the inconsistent findings could be differences in comorbidity distributions between clinic-based patients and population-based controls [7, 16]. Of note, the proportion of clinic-based patients with systemic comorbidities was higher than that of the healthy general population living in the community [40, 41]. Clinic-based patients who were included as controls in clinic-based studies may be more likely to have AMD [42–44]. This may be attributed to a selection bias in these studies. A better understanding of the reasons for the inconsistent findings across studies is important for clinical health practice and future research.

There are two possible reasons that might explain the association between cataract surgery and the development or progression of AMD. One possible explanation is light toxicity. Light, particularly short-wavelength light, can lead to the liberation of reactive oxygen species, which are highly toxic and can cause the formation of toxic lipid and protein peroxidation products [45]. Removal of the cataract exposes the retina to certain short wavelengths of light (e.g., ultraviolet or blue light), damaging the retina and increasing the risk of AMD development [39]. Additionally, the phototoxic effects in turn can lead to chronic inflammation by dendritic cells mediated by the local autoimmune response [46]. Most of the participants had surgery after the introduction of lenses with some blue-light-blocking ability. However, there is no evidence to date that supports the use of blue-blocking IOLs for the prevention of AMD [47]. A further possible explanation is the inflammation that could be induced during cataract surgery, especially in the early days of extracapsular/intracapsular cataract surgery.

However, studies also found that cataract surgery was beneficial for AMD patients in both improving visual acuity and improving quality of life [48, 49]. The majority of patients with late AMD (75.6%) still report significantly greater satisfaction with vision after cataract surgery, although the declining rate of visual acuity is faster in patients with AMD [50]. Physicians must balance the risks and benefits for patients with both visually significant cataracts and AMD [51]. Additionally, an informed discussion between physicians and patients is important based on currently available evidence. Our results show that the development and progression of AMD did not reach statistical significance for a follow-up duration less than 5 years postoperatively. Thus, cataract surgery seems to be beneficial for AMD patients when the age of AMD and cataract patients is taken into consideration.

The present meta-analysis had several limitations. First, the different strategies of the studies for adjusting for potential confounders limit the generalization of the results. We tried to overcome this problem by performing subgroup analyses in more homogeneous subsets of studies. Second, the classification of AMD severity differed among studies and could reduce the comparison of individual studies, but our meta-analysis showed low to moderate homogeneity among studies. Third, this meta-analysis was limited by the original study design of the trials and could not assess the efficacy of the type of implanted lenses and different surgical interventions for age-related cataracts in the development of AMD.

In conclusion, the results of the present meta-analysis suggest that cataract surgery may be a more important risk factor for those who are already at relatively high risk of incident late AMD. In addition, increasing the follow-up time since cataract surgery may further increase the risk for the development and progression of AMD. However, these findings should be considered carefully because some studies were rated as having a high risk of bias. In the future, prospective multicenter studies with well-designed RCTs are required to confirm our findings.

Acknowledgments

This study was supported by Science and Technology Project of Tianjin Health and Health Committee (grant number RC20055) and Tianjin Key Medical Discipline (Specialty) Construction Project.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors' Contributions

LHX, ZXH, and YLH were involved in the design, analysis, and manuscript preparation. LHX and YLH were involved in the literature searching, screening, and data collection. LHX and ZXH assessed the quality of included studies. PY was involved in the study concept and design and approval of the final version of the work. All authors have read and approved the manuscript.

Supplementary Materials

Supplementary Materials

Additional file 1: the detailed search strategy for Embase and PubMed database. Additional file 2: the adjusted study-specific OR estimates (95% CIs) obtained from each study and covariates that were adjusted for in the multivariate analyses. Additional file 3: the quality of the studies included in the meta-analysis. Additional file 4: forest plot evaluating the association between cataract surgery and the development of late AMD by removing clinic-based study for late AMD subtypes. Additional file 5: forest plot evaluating the association between cataract surgery and the development of early AMD based on sample source. Additional file 6: forest plot evaluating the association between cataract surgery and the development of late AMD based on sample source. Additional file 7: forest plot evaluating the association between cataract surgery and the development of late AMD based on adjustment for early AMD lesions.

Click here for additional data file. (1MB, docx)

References

  • 1.Pascolini D., Mariotti S. P., Pokharel G. P., et al. 2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiology . 2004;11(2):67–115. doi: 10.1076/opep.11.2.67.28158. [DOI] [PubMed] [Google Scholar]
  • 2.Chou R., Dana T., Bougatsos C., Grusing S., Blazina I. Screening for impaired visual acuity in older adults: updated evidence report and systematic review for the US preventive services task force. JAMA . 2016;315(9):915–933. doi: 10.1001/jama.2016.0783. [DOI] [PubMed] [Google Scholar]
  • 3.Pascolini D., Mariotti S. P. Global estimates of visual impairment: 2010. British Journal of Ophthalmology . 2012;96(5):614–618. doi: 10.1136/bjophthalmol-2011-300539. [DOI] [PubMed] [Google Scholar]
  • 4.Javitt J. C., Steinberg E. P., Sharkey P., et al. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology . 1995;102(11):1583–1592. doi: 10.1016/s0161-6420(95)30824-x. [DOI] [PubMed] [Google Scholar]
  • 5.Pauleikhoff D. Neovascular age-related macular degeneration: natural History and Treatment Outcomes. Retina . 2005;25(8):1065–1084. doi: 10.1097/00006982-200512000-00016. [DOI] [PubMed] [Google Scholar]
  • 6.Teh B. L., Megaw R., Borooah S., Dhillon B. Optimizing cataract surgery in patients with age-related macular degeneration. Survey of Ophthalmology . 2017;62(3):346–356. doi: 10.1016/j.survophthal.2016.12.003. [DOI] [PubMed] [Google Scholar]
  • 7.Klein B. E. K. Is the risk of incidence or progression of age-related macular degeneration increased after cataract surgery? Archives of Ophthalmology . 2009;127(11):1528–1529. doi: 10.1001/archophthalmol.2009.258. [DOI] [PubMed] [Google Scholar]
  • 8.Sutter F. K. P., Menghini M., Barthelmes D., et al. Is pseudophakia a risk factor for neovascular age-related macular degeneration? Investigative Ophthalmology & Visual Science . 2007;48(4):1472–1475. doi: 10.1167/iovs.06-0766. [DOI] [PubMed] [Google Scholar]
  • 9.Klein R., Klein B. E., Wong T. Y. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Archives of Ophthalmology . 2002;120(11):1551–1558. doi: 10.1001/archopht.120.11.1551. [DOI] [PubMed] [Google Scholar]
  • 10.Cugati S., Mitchell P., Rochtchina E., Tan A. G., Smith W., Wang J. J. Cataract surgery and the 10-year incidence of age-related maculopathy: the blue Mountains eye study. Ophthalmology . 2006;113(11):2020–2025. doi: 10.1016/j.ophtha.2006.05.047. [DOI] [PubMed] [Google Scholar]
  • 11.Ho L., Boekhoorn S. S., Liana, et al. Cataract surgery and the risk of aging macula disorder: the rotterdam study. Investigative Ophthalmology & Visual Science . 2008;49(11):4795–4800. doi: 10.1167/iovs.08-2066. [DOI] [PubMed] [Google Scholar]
  • 12.Klein B. E., Howard K. P., Lee K. E., Iyengar S. K., Sivakumaran T. A., Klein R. The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology . 2012;119(8):1628–1633. doi: 10.1016/j.ophtha.2012.01.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Freeman E. E., Munoz B., West S. K., Tielsch J. M., Schein O. D. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. American Journal of Ophthalmology . 2003;135(6):849–856. doi: 10.1016/s0002-9394(02)02253-5. [DOI] [PubMed] [Google Scholar]
  • 14.Fraser-Bell S., Choudhury F., Klein R., Azen S., Varma R. Ocular risk factors for age-related macular degeneration: the los angeles latino eye study. American Journal of Ophthalmology . 2010;149(5):735–740. doi: 10.1016/j.ajo.2009.11.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chew E. Y., Sperduto R. D., Milton R. C., et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology . 2009;116(2):297–303. doi: 10.1016/j.ophtha.2008.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wang J. J., Fong C. S. U, Rochtchina E., et al. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons. Ophthalmology . 2012;119(11):2298–2303. doi: 10.1016/j.ophtha.2012.07.003. [DOI] [PubMed] [Google Scholar]
  • 17.Ho J. D., Xirasagar S., Kao L. T., Lin H. C. Neovascular age-related macular degeneration is associated with cataract surgery. Acta Ophthalmologica . 2018;96(2):e213–e217. doi: 10.1111/aos.13511. [DOI] [PubMed] [Google Scholar]
  • 18.Buch H., Vinding T., la Cour M., Jensen G. B., Prause J. U., Nielsen N. V. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmologica Scandinavica . 2005;83(4):409–418. doi: 10.1111/j.1600-0420.2005.00492.x. [DOI] [PubMed] [Google Scholar]
  • 19.Baatz H., Darawsha R., Ackermann H., et al. Phacoemulsification does not induce neovascular age-related macular degeneration. Investigative Ophthalmology & Visual Science . 2008;49(3):1079–1083. doi: 10.1167/iovs.07-0557. [DOI] [PubMed] [Google Scholar]
  • 20.Daien V., Nguyen V., Morlet N., et al. Outcomes and predictive factors after cataract surgery in patients with neovascular age-related macular degeneration. The fight retinal blindness! Project. American Journal of Ophthalmology . 2018;190:50–57. doi: 10.1016/j.ajo.2018.03.012. [DOI] [PubMed] [Google Scholar]
  • 21.Park S. J., Lee J. H., Ahn S., Park K. H. Cataract surgery and age-related macular degeneration in the 2008-2012 korea national health and nutrition examination survey. JAMA Ophthalmol . 2016;134(6):621–626. doi: 10.1001/jamaophthalmol.2016.0453. [DOI] [PubMed] [Google Scholar]
  • 22.Kessel L., Erngaard D., Flesner P., Andresen J., Tendal B., Hjortdal J. Cataract surgery and age-related macular degeneration. An evidence-based update. Acta Ophthalmologica . 2015;93(7):593–600. doi: 10.1111/aos.12665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chakravarthy U., Wong T. Y., Fletcher A., et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmology . 2010;10(1):p. 31. doi: 10.1186/1471-2415-10-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Stroup D. F., Berlin J. A., Morton S. C. Meta-analysis of observational studies in Epidemiology: A proposal for reporting. JAMA . 2000;283(15):2008–2012. doi: 10.1001/jama.283.15.2008. [DOI] [PubMed] [Google Scholar]
  • 25.Hooper C. Y., Lamoureux E. L., Lim L., et al. Cataract surgery in high-risk age-related macular degeneration: a randomized controlled trial. Clinical and Experimental Ophthalmology . 2009;37(6):570–576. doi: 10.1111/j.1442-9071.2009.02095.x. [DOI] [PubMed] [Google Scholar]
  • 26.Brunner S., Mora A., Fonseca J., et al. Monitoring of drusen and geographic atrophy area size after cataract surgery using the MD3RI tool for computer-aided contour drawing. Ophthalmologica . 2013;229(2):86–93. doi: 10.1159/000345492. [DOI] [PubMed] [Google Scholar]
  • 27.Casparis H., Lindsley K., Kuo I. C., Sikder S., Bressler N. M. Surgery for cataracts in people with age-related macular degeneration. Cochrane Database of Systematic Reviews . 2012;6 doi: 10.1002/14651858.cd006757.pub3.CD006757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sterne J. A., Hernan M. A., Reeves B. C., et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ . 2016;355 doi: 10.1136/bmj.i4919.i4919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Higgins J. P. T., Altman D. G., Gotzsche P. C., et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ . 2011;343 doi: 10.1136/bmj.d5928.d5928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Klein R., Klein B. E., Jensen S. C., Cruickshanks K. J. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Archives of Ophthalmology . 1998;116(4):506–513. doi: 10.1001/archopht.116.4.506. [DOI] [PubMed] [Google Scholar]
  • 31.Kaiserman I., Kaiserman N., Elhayany A., Vinker S. Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degeneration. Ophthalmology . 2007;114(2):278–282. doi: 10.1016/j.ophtha.2006.10.019. [DOI] [PubMed] [Google Scholar]
  • 32.Hamling J., Lee P., Weitkunat R., Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Statistics in Medicine . 2008;27(7):954–970. doi: 10.1002/sim.3013. [DOI] [PubMed] [Google Scholar]
  • 33.Ades A. E., Lu G., Higgins J. P. T. The interpretation of random-effects meta-analysis in decision models. Medical Decision Making . 2005;25(6):646–654. doi: 10.1177/0272989x05282643. [DOI] [PubMed] [Google Scholar]
  • 34.Higgins J. P. T., Thompson S. G. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine . 2002;21(11):1539–1558. doi: 10.1002/sim.1186. [DOI] [PubMed] [Google Scholar]
  • 35.Higgins J. P. T., Thompson S. G., Deeks J. J., Altman D. G. Measuring inconsistency in meta-analyses. BMJ . 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Egger M., Smith G. D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ . 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wang J. J., Klein R., Smith W., Klein B. E. K., Tomany S., Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology . 2003;110(10):1960–1967. doi: 10.1016/s0161-6420(03)00816-9. [DOI] [PubMed] [Google Scholar]
  • 38.Ehmann D. S., Ho A. C. Cataract surgery and age-related macular degeneration. Current Opinion in Ophthalmology . 2017;28(1):58–62. doi: 10.1097/icu.0000000000000331. [DOI] [PubMed] [Google Scholar]
  • 39.de Jong P. T. Age-related macular degeneration. New England Journal of Medicine . 2006;355(14):1474–1485. doi: 10.1056/nejmra062326. [DOI] [PubMed] [Google Scholar]
  • 40.Riley A. F., Malik T. Y., Grupcheva C. N. The Auckland cataract study: co-morbidity, surgical techniques, and clinical outcomes in a public hospital service. British Journal of Ophthalmology . 2002;86(2):185–190. doi: 10.1136/bjo.86.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Reeves S. W., Tielsch J. M., Katz J., Bass E. B., Schein O. D. A self-administered health questionnaire for the preoperative risk stratification of patients undergoing cataract surgery. American Journal of Ophthalmology . 2003;135(5):599–606. doi: 10.1016/s0002-9394(02)02236-5. [DOI] [PubMed] [Google Scholar]
  • 42.Fraser-Bell S., Wu J., Klein R., et al. Cardiovascular risk factors and age-related macular degeneration: the los angeles latino eye study. American Journal of Ophthalmology . 2008;145(2):308–316. doi: 10.1016/j.ajo.2007.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Tan J. S., Mitchell P., Smith W., Wang J. J. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration. Ophthalmology . 2007;114(6):1143–1150. doi: 10.1016/j.ophtha.2006.09.033. [DOI] [PubMed] [Google Scholar]
  • 44.Klein R., Deng Y., Klein B. E., et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: women’s Health Initiative Sight Exam ancillary study. American Journal of Ophthalmology . 2007;143(3):473–483.e2. doi: 10.1016/j.ajo.2006.11.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Margrain T. H., Boulton M., Marshall J., Sliney D. H. Do blue light filters confer protection against age-related macular degeneration? Progress in Retinal and Eye Research . 2004;23(5):523–531. doi: 10.1016/j.preteyeres.2004.05.001. [DOI] [PubMed] [Google Scholar]
  • 46.McGeer P. L., McGeer E. G. Inflammation and the degenerative diseases of aging. Annals of the New York Academy of Sciences . 2004;1035(1):104–116. doi: 10.1196/annals.1332.007. [DOI] [PubMed] [Google Scholar]
  • 47.Henderson B. A., Grimes K. J. Blue-blocking IOLs: a complete review of the literature. Survey of Ophthalmology . 2010;55(3):284–289. doi: 10.1016/j.survophthal.2009.07.007. [DOI] [PubMed] [Google Scholar]
  • 48.Stock M. V., Vollman D. E., Baze E. F., Chomsky A. S., Daly M. K., Lawrence M. G. Functional visual improvement after cataract surgery in eyes with age-related macular degeneration: results of the ophthalmic surgical outcomes data Project. Investigative Ophthalmology & Visual Science . 2015;56(4):2536–2540. doi: 10.1167/iovs.14-16069. [DOI] [PubMed] [Google Scholar]
  • 49.Kim J. H., Ryu C. L., Ober M. D. The effects of cataract surgery on patients with wet macular degeneration. American Journal of Ophthalmology . 2015;160(6):1312–1392 e1. doi: 10.1016/j.ajo.2015.09.012. [DOI] [PubMed] [Google Scholar]
  • 50.Lundstrom M., Brege K. G., Floren I. Cataract surgery and quality of life in patients with age related macular degeneration. British Journal of Ophthalmology . 2002;86(12):1330–1335. doi: 10.1136/bjo.86.12.1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wong T. Y. Cataract surgery in patients with cataract and age related macular degeneration: do the benefits outweigh the risks? British Journal of Ophthalmology . 2000;84(12):1337–1338. doi: 10.1136/bjo.84.12.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Materials

Additional file 1: the detailed search strategy for Embase and PubMed database. Additional file 2: the adjusted study-specific OR estimates (95% CIs) obtained from each study and covariates that were adjusted for in the multivariate analyses. Additional file 3: the quality of the studies included in the meta-analysis. Additional file 4: forest plot evaluating the association between cataract surgery and the development of late AMD by removing clinic-based study for late AMD subtypes. Additional file 5: forest plot evaluating the association between cataract surgery and the development of early AMD based on sample source. Additional file 6: forest plot evaluating the association between cataract surgery and the development of late AMD based on sample source. Additional file 7: forest plot evaluating the association between cataract surgery and the development of late AMD based on adjustment for early AMD lesions.

Click here for additional data file. (1MB, docx)

Articles from Journal of Ophthalmology are provided here courtesy of Wiley

RESOURCES